Cercar
09/03/2022
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial
Paez-Vega, A, Gutierrez-Gutierrez, B, Aguera, ML, Facundo, C, Redondo-Pachon, D, Suner, M, Lopez-Oliva, MO, Yuste, JR, Montejo, M, Galeano-Alvarez, C, Ruiz-San Millan, JC, Los-Arcos, I, Hernandez, D, Fernandez-Ruiz, M, Munoz, P, Valle-Arroyo, J, Cano, A, Rodriguez-Benot, A, Crespo, M, Rodelo-Haad, C, Lobo-Acosta, MA, Garrido-Gracia, JC, Vidal, E, Guirado, L, Cantisan, S, Torre-Cisneros, J. Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial. CLINICAL INFECTIOUS DISEASES. 2022; 74(5)DOI:10.1093/cid/ciab574. PMID:34228099. IF:11.800(Q1/1D).
25/02/2022
Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study
Aapkes, SE, Bernts, LHP, van den Berg, AP, van den Berg, M, Blokzijl, H, Cantineau, AEP, van Gastel, MDA, de Haas, RJ, Kappert, P, Muller, RU, Nevens, F, Torra, R, Visser, A, Drenth, JPH, Gansevoort, RT. Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study. BMC GASTROENTEROLOGY. 2022; 22(1)DOI:10.1186/s12876-022-02142-y. PMID:35216547. IF:2.400(Q4/9D).
22/02/2022
The ERA Registry Annual Report 2019: summary and age comparisons
Boenink, R, Astley, ME, Huijben, JA, Stel, VS, Kerschbaum, J, Ots-Rosenberg, M, Asberg, AA, Lopot, F, Golan, E, de la Nuez, PC, Camblor, MR, Trujillo-Aleman, S, San Millan, JCR, Mingo, PU, Diaz, JM, Bouzas-Caamano, ME, Artamendi, M, Madre, MA, de Pablos, CS, Roblero, MFS, Zurriaga, O, Stendahl, ME, Bell, S, Idrizi, A, Ioannou, K, Debska-Slizien, A, Galvao, AA, De Meester, JM, Resic, H, Hommel, K, Radunovic, D, Palsson, R, Lassalle, M, Finne, P, Bazaga, MD, Gjorgjievski, N, Seyahi, N, Bonthuis, M, Ortiz, A, Jager, KJ, Kramer, A. The ERA Registry Annual Report 2019: summary and age comparisons. Clinical Kidney Journal. 2022; 15(3)DOI:10.1093/ckj/sfab273. PMID:35211303. IF:4.600(Q1/2D).
08/02/2022
Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?
Hughes, DA, Aguiar, P, Lidove, O, Nicholls, K, Nowak, A, Thomas, M, Torra, R, Vujkovac, B, West, ML, Feriozzi, S. Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?. Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02181-4. PMID:35135579. IF:3.700(Q2/4D).
01/02/2022
Assessment of Tacrolimus Neurotoxicity Measured by Retinal OCT
Ahmadian, KM, Cabanas, NS, Herrera, CC, de Arizon, LF, Mir, MP, Perich, LG, Molas, CF. Assessment of Tacrolimus Neurotoxicity Measured by Retinal OCT. TRANSPLANTATION PROCEEDINGS. 2022; 54(1)DOI:10.1016/j.transproceed.2021.10.013. PMID:34911620. IF:0.900(Q4/9D).
07/01/2022
A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment
Banas, MC, Bohmig, GA, Viklicky, O, Rostaing, LP, Jouve, T, Guirado, L, Facundo, C, Bestard, O, Grone, HJ, Kobayashi, K, Hanzal, V, Putz, FJ, Zecher, D, Bergler, T, Neumann, S, Rothe, V, Santamaria, ASG, Schiffer, E, Banas, B. A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment. Frontiers in Medicine. 2022; 8DOI:10.3389/fmed.2021.780585. PMID:35071266. IF:3.900(Q2/4D).
01/01/2022
The Role of Arterial Stiffness in the Estimation of Cardiovascular Risk in Liver Transplant Recipients
Sastre, L, Garcia, R, Gandara, JG, Fernandez-Llama, P, Amor, AJ, Sierra, C, Escude, L, Ruiz, P, Colmenero, J, Ortega, E, Navasa, M, Crespo, G. The Role of Arterial Stiffness in the Estimation of Cardiovascular Risk in Liver Transplant Recipients. Transplantation Direct. 2022; 8(1)DOI:10.1097/TXD.0000000000001272. PMID:34966842. IF:(Q/D).
01/01/2022
The 2019 and 2021 International Workshops on Alport Syndrome
Daga, S, Ding, J, Deltas, C, Savige, J, Lipska-Zietkiewicz, BS, Hoefele, J, Flinter, F, Gale, DP, Aksenova, M, Kai, H, Perin, L, Barua, M, Torra, R, Miner, JH, Massella, L, Ljubanovic, DG, Lennon, R, Weinstock, AB, Knebelmann, B, Cerkauskaite, A, Gear, S, Gross, O, Turner, AN, Baldassarri, M, Pinto, AM, Renieri, A. The 2019 and 2021 International Workshops on Alport Syndrome. EUROPEAN JOURNAL OF HUMAN GENETICS. 2022; 30(5)DOI:10.1038/s41431-022-01075-0. PMID:35260866. IF:5.200(Q1/2D).